Guoliang Wang Rui Fan Ruirui Ji Wenxin Zou Daniel J Penny Nidhy P Varghese Yuxin Fan
10.1186/s12890-016-0183-7
BMC Pulm Med
2016 Jan 22;16:17.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26801773/
Growth Differentiation Factors / genetics Hypertension, Pulmonary / genetics Mexican Americans / genetics
Growth Differentiation Factors / genetics Hypertension, Pulmonary / genetics Mexican Americans / genetics Case Reports Research Support, Non-U.S. Gov't Anticoagulants / therapeutic use Antihypertensive Agents / therapeutic use Bosentan Child, Preschool Codon, Nonsense Epoprostenol / analogs & derivatives Epoprostenol / therapeutic use Growth Differentiation Factor 2 Homozygote Humans Hypertension, Pulmonary / drug therapy Male Sildenafil Citrate / therapeutic use Sulfonamides / therapeutic use Vasodilator Agents / therapeutic use Warfarin / therapeutic use Anticoagulants Antihypertensive Agents Codon, Nonsense GDF2 protein, human Growth Differentiation Factor 2 Growth Differentiation Factors Sulfonamides Vasodilator Agents Warfarin Sildenafil Citrate Epoprostenol Bosentan treprostinil
PMC4722683
26801773
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report
2016